Does RAVULIZUMAB-CWVZ Cause Off label use? 451 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 451 reports of Off label use have been filed in association with RAVULIZUMAB-CWVZ. This represents 4.4% of all adverse event reports for RAVULIZUMAB-CWVZ.
451
Reports of Off label use with RAVULIZUMAB-CWVZ
4.4%
of all RAVULIZUMAB-CWVZ reports
9
Deaths
44
Hospitalizations
How Dangerous Is Off label use From RAVULIZUMAB-CWVZ?
Of the 451 reports, 9 (2.0%) resulted in death, 44 (9.8%) required hospitalization, and 4 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 451 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
Back pain (326)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Off label use Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST